A vaccine for Ebola virus that employs virus-like particles instead of live infectious virus to evoke an immune response has shown promise in laboratory chimpanzees, according to a study. Chimpanzees and gorillas are threatened by recent Ebola virus outbreaks, which have killed nearly one third of the world's gorillas, now classified as critically endangered.
↧